Drugs, Sex, and Enhancement: Threats to Sports Integrity at the Olympics
Overview
Overview
Journal
Innovation (Camb)
Publisher
Cell Press
Specialty
Biomedical Engineering
Date
2024 Sep 4
PMID
39228855
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bejder J, Andersen A, Bonne T, Linkis J, Olsen N, Huertas J
. Hematological adaptations and detection of recombinant human erythropoietin combined with chronic hypoxia. Drug Test Anal. 2020; 13(2):360-368.
DOI: 10.1002/dta.2931.
View
2.
Pitsiladis Y, Pigozzi F, Geistlinger M, Kawazoe Lazzoli J, Zahar M, Bachl N
. We want healthy athletes and fair competition. Br J Sports Med. 2024; 58(14):760-763.
PMC: 11228201.
DOI: 10.1136/bjsports-2024-108581.
View
3.
Harper J, Lima G, Kolliari-Turner A, Malinsky F, Wang G, Martinez-Patino M
. The Fluidity of Gender and Implications for the Biology of Inclusion for Transgender and Intersex Athletes. Curr Sports Med Rep. 2018; 17(12):467-472.
DOI: 10.1249/JSR.0000000000000543.
View
4.
Wang G, Durussel J, Shurlock J, Mooses M, Fuku N, Bruinvels G
. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration. BMC Genomics. 2017; 18(Suppl 8):817.
PMC: 5688496.
DOI: 10.1186/s12864-017-4191-7.
View
5.
Gleaves J, Petroczi A, Folkerts D, de Hon O, Macedo E, Saugy M
. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence. Sports Med. 2021; 51(9):1909-1934.
DOI: 10.1007/s40279-021-01477-y.
View